These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15735606)

  • 1. Pharmacogenetics and response to beta-adrenergic receptor antagonists in heart failure.
    Muszkat M; Stein CM
    Clin Pharmacol Ther; 2005 Mar; 77(3):123-6. PubMed ID: 15735606
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
    Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
    Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics in heart failure: promises and challenges.
    de Boer RA; van der Harst P; van Veldhuisen DJ; van den Berg MP
    Expert Opin Pharmacother; 2009 Aug; 10(11):1713-25. PubMed ID: 19558337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.
    Terra SG; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hamilton KK; Aranda JM; Hill JA; Yarandi HN; Walker JR; Phillips MS; Gelfand CA; Johnson JA
    Clin Pharmacol Ther; 2005 Mar; 77(3):127-37. PubMed ID: 15735607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics for neurohormonal intervention in heart failure.
    McNamara DM
    Heart Fail Clin; 2005 Apr; 1(1):141-50. PubMed ID: 17386840
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacogenetics of beta1-adrenergic receptors in heart failure and hypertension.
    Mialet-Perez J; Liggett SB
    Arch Mal Coeur Vaiss; 2006 Jun; 99(6):616-20. PubMed ID: 16878723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ile164 variant of beta2-adrenoceptor does not influence outcome in heart failure but may interact with beta blocker treatment.
    Littlejohn MD; Palmer BR; Richards AM; Frampton CM; Pilbrow AP; Troughton RW; Cameron VA; Kennedy MA
    Eur J Heart Fail; 2008 Jan; 10(1):55-9. PubMed ID: 18068431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacogenetics of β-adrenergic receptor antagonists in the treatment of hypertension and heart failure.
    Chan SW; Hu M; Tomlinson B
    Expert Opin Drug Metab Toxicol; 2012 Jul; 8(7):767-90. PubMed ID: 22621216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of metoprolol on beta1 adrenergic receptor polymorphism and receptor density in urban Chinese patients with heart failure.
    Luo M; Bi Y; Xu YX
    Chin Med J (Engl); 2007 Oct; 120(19):1720-3. PubMed ID: 17935678
    [No Abstract]   [Full Text] [Related]  

  • 10. [Beta receptor blockers: renaissance in therapy of heart failure].
    Klein W
    Wien Klin Wochenschr; 1997 Apr; 109(7):219-21. PubMed ID: 9206900
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta-blocker pharmacogenetics in heart failure.
    Shin J; Johnson JA
    Heart Fail Rev; 2010 May; 15(3):187-96. PubMed ID: 18437562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
    Biolo A; Clausell N; Santos KG; Salvaro R; Ashton-Prolla P; Borges A; Rohde LE
    Am J Cardiol; 2008 Sep; 102(6):726-32. PubMed ID: 18773997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in heart rate turbulence as a measure of response to beta-blocker therapy for heart failure.
    Saxon LA
    J Cardiovasc Electrophysiol; 2004 Jul; 15(7):757-8. PubMed ID: 15250857
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic heart failure: beta-blockers and pharmacogenetics.
    Azuma J; Nonen S
    Eur J Clin Pharmacol; 2009 Jan; 65(1):3-17. PubMed ID: 18839161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacogenetics of chronic heart failure--beta blockers].
    Vasků A; Spinarová L; Pávková-Goldbergová M; Spinar J; Soucek M; Vítovec J
    Cas Lek Cesk; 2006; 145(2):148-52; discussion 152-3. PubMed ID: 16521406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of disease: beta-adrenergic receptors--alterations in signal transduction and pharmacogenomics in heart failure.
    Feldman DS; Carnes CA; Abraham WT; Bristow MR
    Nat Clin Pract Cardiovasc Med; 2005 Sep; 2(9):475-83. PubMed ID: 16265588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure management: 25 years of progress.
    Sharpe N
    N Z Med J; 2001 Feb; 114(1125):23-4. PubMed ID: 11277469
    [No Abstract]   [Full Text] [Related]  

  • 19. The future of pharmacogenetics in the treatment of heart failure.
    Anwar MS; Iskandar MZ; Parry HM; Doney AS; Palmer CN; Lang CC
    Pharmacogenomics; 2015 Nov; 16(16):1817-27. PubMed ID: 26555119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta blockers in systolic heart failure: do physicians need more courage?
    Yilmaz MB; Refiker M
    Am Heart J; 2007 Nov; 154(5):e23; author reply e25. PubMed ID: 17967570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.